Dow Up 0.00% Nasdaq Up 0.09%

MannKind Corp. (MNKD)

-NasdaqGM
6.15 Down 0.11(1.76%) Nov 28, 1:00PM EST
Prev Close:6.26
Open:6.24
Bid:6.12 x 1500
Ask:6.15 x 1800
1y Target Est:8.93
Beta:3.22
Earnings Date:Feb 16 - Feb 20 (Est.)
Day's Range:5.60 - 6.29
52wk Range:3.80 - 11.48
Volume:2,905,037
Avg Vol (3m):5,399,740
Market Cap:2.44B
P/E (ttm):N/A
EPS (ttm):-0.58
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
MNKDDown 1.76%2.44B
LLYUp 1.19%72.86B
GSKDown 0.15%111.67B
NVOUp 1.18%118.83B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.48
Quarterly EPS Est (Dec-14) :-0.09
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):0.05

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback